Fierce Pharma Politics—Could a Senate drug pricing bill be ‘a positive’ for pharma? One analyst says so esagonowsky […]
Pfizer’s 6-dose-per-vial OK boosts its supply numbers. The catch? Special syringes are required fkansteiner Mon, 01/25/2021 – 09:25
Bristol Myers, Exelixis snag Opdivo-Cabometyx kidney cancer nod to challenge Merck, Pfizer aliu Mon, 01/25/2021 – 08:14
Using mathematical image processing, scientists at the BioTechMed-Graz research cooperation have found a way to create digital twins […]
Viral respiratory diseases are easily transmissible and can spread rapidly across the globe, causing significant damage. The ongoing […]
What’s in a name?General bewilderment, it turns out, when we’re talking about SARS-CoV-2 variants. More and more potentially […]
Promote small acts of kindnessHeidi Edmundson, emergency medicine consultant, says, “It’s important to remember that looking after morale […]
The story behind Resusci Annie and her legacy is interesting,1 but the manikins I have encountered in medical […]
The 2021 International Clinical Researcher of the Year competition will continue the successes of last year and be […]
BTK inhibitor demonstrated non-inferior progression-free survival compared to Imbruvica